Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2010
10/19/2010CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/13/2010EP2238105A2 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
10/13/2010EP2238103A1 Novel n-(2-amino-phenyl)-amide derivatives
10/13/2010CN101104609B Solanesyl polyamine derivative, preparation and application thereof
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812023 Methods of using substituted morpholine derivatives
10/12/2010CA2507691C Method for producing salts of tolperisone
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010113813A1 Base-generating agent, photosensitive resin composition, patterning material comprising the photosensitive resin composition, patterning method and article using the photosensitive resin composition
10/07/2010US20100256231 Novel derivatives of 3,3-diphenylpropylamines
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256163 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
10/07/2010US20100256162 Piperazine and Piperidine Derivatives
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100255117 Methods and compositions for the treatment of cancer
10/06/2010EP2236488A1 Materials, methods and uses for photochemical generation of acids and/or radical species
10/06/2010EP2234992A2 Piperazine derivatives and their use as leptin receptor modulators
10/06/2010EP2234973A1 Anthelmintic agents and their use
10/06/2010EP2234971A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101851143A Method for alkylating amine and amino acid
10/06/2010CN101850270A Application of central palladium phosphine ferrocenylimine complex for catalyzing and synthesizing amine-methylated aromatic compound
10/05/2010US7807681 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/05/2010US7807679 2-chloro-N-(4-chloro-2-{4-[(E)-3-(4-chloro-phenyl)-allyl]-piperazin-1-yl}-phenyl)-isonicotinamide; for insects, acarines, nematodes and molluscs
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
09/2010
09/30/2010WO2010108835A1 Photoresist composition
09/30/2010WO2009154783A3 Synthesis and use of mse-framework type molecular sieves
09/30/2010US20100249412 Process for the manufacture of dihydropteridinones
09/30/2010US20100249411 Stereoselective Alkylation of Chiral 2-Methly-4 Protected Piperazines
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/29/2010EP2231630A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl]cyclobut anecarboxamide
09/29/2010EP2231613A1 Montelukast benzhydryl piperazine salts and process for preparation thereof
09/29/2010EP2231589A2 Aminotetralin compounds as mu opioid receptor antagonists
09/29/2010EP2231586A1 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors
09/29/2010EP1680393B1 Method for the distillative separation of mixtures containing ethyleneamines
09/29/2010CN1934077B 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/28/2010US7803800 Histone deacetylases inhibitors
09/28/2010CA2429267C Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/23/2010US20100240893 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
09/23/2010US20100240694 Salt of naphthyridine carboxylic acid derivative
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/22/2010EP1853565B1 Menthane carboxamide derivatives having cooling properties
09/22/2010CN1658872B Antiallergic
09/22/2010CN101842346A Method for producing amines from sugar alcohols
09/22/2010CN101842345A Method for producing amines from glycerin
09/22/2010CN101842093A PAI-1 production inhibitor
09/22/2010CN101838248A 1,4-naphthoquinone compounds and application thereof
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010US7799772 Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
09/21/2010US7799576 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2338073C Novel urokinase inhibitors
09/16/2010WO2010102663A1 Piperazine derivatives for use in therapy
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010US20100234592 Corrosion Inhibitors Having Increased Biodegradability and Reduced Toxicity
09/16/2010US20100234258 Amine reaction compounds comprising one or more active ingredient
09/15/2010EP2228370A1 N-{1-ý3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl¨ethyl}butyramide, the preparation method and use thereof
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2228362A1 4-hydroxyphenylalkylamine derivative
09/15/2010CN101835761A Substituted piperazines
09/15/2010CN101835750A Cyclopropyl amide derivatives '978
09/15/2010CN101830867A Preparation method of 2-(3,3,5,5-cyclopropylmethyl)aniline
09/15/2010CN101220007B Method for producing repaglinide
09/14/2010US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/14/2010US7795304 such as S)-[6-Hydroxycarbamoyl-1-(4-phenyl-thiazol-2-ylcarbamoyl)-hexyl]-carbamic acid benzyl ester, useful in the prevention and/or treatment cancer, restenosis, autoimmune diseases, allergies, inflammatory diseases, nervous system disorders such as neurodegenerative diseases
09/14/2010US7795266 Tetrahydroindolone derivatives for treament of neurological conditions
09/14/2010US7795262 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
09/14/2010CA2611035C Stereoselective hydrogenation process for preparing cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-2-methoxy-5,6,7,8-tetrahydronaphthalene hydrochloride
09/14/2010CA2597882C Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device
09/14/2010CA2564300C Process for preparation of 3-substituted benzisothiazole
09/14/2010CA2536144C Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/14/2010CA2399395C Arginine mimetics as factor xa inhibitors
09/14/2010CA2394276C Serine protease inhibitors
09/14/2010CA2314771C Method for manufacturing aminoalcohol
09/10/2010WO2010101161A1 Method for producing fullerene film, and fullerene film
09/10/2010WO2010100475A1 Hydroxamic acid derivatives as gram-negative antibacterial agents
09/10/2010WO2010083441A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/08/2010EP2225212A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/08/2010EP2225196A1 Cysteine protease inhibitors for the treatment of parasitic diseases
09/08/2010EP1303525B1 Production of novel phosphane ligands and use in catalytical reactions
09/08/2010EP0770132B1 New streptogramines
09/08/2010CN101824009A Simple preparation method for posaconazole and piperazine intermediate thereof
09/08/2010CN101824008A Preparation method of N,N-dimethyl aminopropyl morpholine
09/08/2010CN101333199B Method for synthesizing 4-(2-(N,N-dimethylamino)ethyl)morpholine
09/08/2010CN101048369B Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
09/07/2010US7790727 4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methoxy-phenyl]- piperazine-1-carboxylic acid tert-butyl ester; nervous system disorders, particularly the central nervous system; obesity; cogition activators; Alzheimer's disease; drug abuse, drug dependence; schizophrenia; bioavailability; stability
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 341